The Remus Pharmaceuticals IPO has begun on 17 May 2023. It will close on 19 May 2023. The Total IPO Size is 47.69 Crore. The company set its IPO price is 1150-1229 Rs Per Share. Basically, There are three basic categories in Remus Pharmaceuticals IPO Subscription 1) QIB 2) Non-Institutional Investors 3) Retail Individual Investors (RIIs)
Remus Pharmaceuticals is established in 2015.
Remus Pharmaceuticals is engaged marketing & distribution of finished formulations of pharmaceutical drugs. They also deals in API (Active Pharmaceutical Ingredient). They also provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
Their client are spread in more than 20 countries. They have product portfolio consists of 429 products as on 31 January,2023.
Check :- Upcoming SME IPO 2023
Peers
There are no listed companies in India.
Remus Pharmaceuticals IPO Promotors
| Name of the Promoter | No. of Shares held | Average cost of Acquisition (in ₹ ) |
| Arpit Deepakkumar Shah | 2,50,000 | 0.1000 |
| Roma Vinodbhai Shah | 2,50,000 | 0.1000 |
| Swapnil Jatinbhai Shah | 2,50,000 | 0.0620 |
| Anar Swapnil Shah | 2,50,000 | 9.4460 |
| Total Pre Issue | 10,00,000 (92.16%) | |
* The company gives a bonus in the year of March 28, 2023 ( Ratio: 99:1 means 99 Bonus Equity Shares for 1 equity share).
Remus Pharmaceuticals IPO Date, Details & Price Band
| IPO Opening Dates | 17 May 2023 |
| IPO Closing Dates | 19 May 2023 |
| Price Band | 1150-1229 Rs Per Share |
| Fresh issue | 47.69 Crore |
| Total IPO size | 47.69 Crore |
| Minimum bid (lot size) | 100 Shares |
| Face Value | 10 INR Per Share |
| QIB | 50% |
| Non-Institutional | 15% |
| Retail Allocation | 35% |
| Listing On | NSE SME |
Remus Pharmaceuticals IPO Market Lot
The Remus Pharmaceuticals IPO minimum market lot is 100 shares With 1,22,900 ₹ Amount per application.
| Lot | No of Shares | Amount | |
| Minimum | 1 | 100 | 1,22,900 Rs |
| Maximum | 1 | 100 | 1,22,900 Rs |
| S-HNI (Min) | 2 | 200 | 2,45,800 Rs |
Restated Financial Record of the three year (Amt. in Lakhs)
| Total Assets | Total Revenue | Profit After Tax | |
| 31-Mar-21 | 1,104.96 | 1,922.45 | 102.58 |
| 31-Mar-22 | 1,590.93 | 2,543.71 | 338.57 |
| 31-Dec-22 | 3,352.96 | 3,361.20 | 643.90 |
| EPS(₹) | NAV(₹) | RoNW (%) | borrowings (Lakhs) | |
| 31-Mar-21 | 10.26 | 30.46 | 33.68 | 27.89 |
| 31-Mar-22 | 33.86 | 64.32 | 52.64 | 19.17 |
| 31-Dec-22 | 64.35 | 157.79 | 37.61 | 947.45 |
Remus Pharmaceuticals IPO GMP Grey Market Premium
Remus Pharmaceuticals IPO GMP Grey market premium has been started today. Check Latest Remus Pharmaceuticals IPO GMP Grey market premium, Kostak Rates and Subject to Sauda Price here.
Remus Pharmaceuticals IPO Prospectus
| DRHP | Download |
| RHP | Download |
Remus Pharmaceuticals IPO Reviews
Angel Broking – Update Soon
Choice Broking – Update Soon
Prabhudas Lilladher – Update Soon
Remus Pharmaceuticals IPO Form Download
Remus Pharmaceuticals IPO is available on NSE Website as well as on our Portal. Please click here Remus Pharmaceuticals IPO form Download.
Remus Pharmaceuticals IPO Allotment Date & Details
| Allotment Date | 24 May 2023 |
| Initiation of refunds | 25 May 2023 |
| Transfer of shares to Demat accounts | 26 May 2023 |
| Listing Date | 29 May 2023 |
| Check Allotment Status | Click here |
Registrar of Remus Pharmaceuticals IPO
LINK INTIME INDIA PRIVATE LIMITED
SEBI Registration Number: INR000004058
Address: C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai,
Maharashtra, India – 400 083.
Tel. Number: +91 810 811 4949 Fax- +91 22 4918 6195
Email Id: [email protected]
Investors Grievance Id: [email protected]
Website: www.linkintime.co.in
Contact Person: Shanti Goapalkrishnan
CIN: U67190MH1999PTC118368
Remus Pharmaceuticals Contact Details
Remus Pharmaceuticals Limited
1101 to 1103, South Tower, One 42,
B/H Ashok Vatika, Nr. Jayantilal Park BRTS,
Ambli bopal Road, Ahmedabad – 380054
Phone: +079- 2999 9857
Email: [email protected]
Website: http://www.remuspharma.com/
Remus Pharmaceuticals IPO Lead Managers
BEELINE CAPITAL ADVISORS PRIVATE LIMITED
SEBI Registration Number: INM000012917
Address: 807, Phoenix, Opp. Girish Cold Drinks, Near Vijay Cross Roads, Navrangpura,
Ahmedabad -380009, Gujarat.
Telephone Number: 079 4840 5357
Email Id: [email protected]
Investors Grievance Id: [email protected]
Website: www.beelinemb.com
Contact Person: Mr. Nikhil Shah
CIN: U67190GJ2020PTC114322